全文获取类型
收费全文 | 3184篇 |
免费 | 170篇 |
国内免费 | 36篇 |
专业分类
耳鼻咽喉 | 52篇 |
儿科学 | 118篇 |
妇产科学 | 53篇 |
基础医学 | 352篇 |
口腔科学 | 169篇 |
临床医学 | 223篇 |
内科学 | 561篇 |
皮肤病学 | 80篇 |
神经病学 | 243篇 |
特种医学 | 211篇 |
外科学 | 557篇 |
综合类 | 76篇 |
预防医学 | 269篇 |
眼科学 | 33篇 |
药学 | 206篇 |
中国医学 | 1篇 |
肿瘤学 | 186篇 |
出版年
2022年 | 34篇 |
2021年 | 47篇 |
2020年 | 31篇 |
2019年 | 33篇 |
2018年 | 46篇 |
2017年 | 47篇 |
2016年 | 47篇 |
2015年 | 56篇 |
2014年 | 73篇 |
2013年 | 92篇 |
2012年 | 114篇 |
2011年 | 129篇 |
2010年 | 86篇 |
2009年 | 103篇 |
2008年 | 122篇 |
2007年 | 146篇 |
2006年 | 136篇 |
2005年 | 135篇 |
2004年 | 165篇 |
2003年 | 119篇 |
2002年 | 101篇 |
2001年 | 113篇 |
2000年 | 119篇 |
1999年 | 107篇 |
1998年 | 81篇 |
1997年 | 50篇 |
1996年 | 77篇 |
1995年 | 49篇 |
1994年 | 34篇 |
1993年 | 40篇 |
1992年 | 65篇 |
1991年 | 67篇 |
1990年 | 51篇 |
1989年 | 53篇 |
1988年 | 62篇 |
1987年 | 54篇 |
1986年 | 43篇 |
1985年 | 58篇 |
1984年 | 30篇 |
1983年 | 19篇 |
1981年 | 17篇 |
1980年 | 17篇 |
1979年 | 17篇 |
1977年 | 23篇 |
1975年 | 16篇 |
1973年 | 16篇 |
1972年 | 16篇 |
1971年 | 19篇 |
1969年 | 21篇 |
1967年 | 20篇 |
排序方式: 共有3390条查询结果,搜索用时 0 毫秒
101.
Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression 总被引:18,自引:26,他引:18
Sullivan KM; Shulman HM; Storb R; Weiden PL; Witherspoon RP; McDonald GB; Schubert MM; Atkinson K; Thomas ED 《Blood》1981,57(2):267-276
Fifty-two of 175 (30%) survivors of allogeneic marrow transplantation developed chronic graft-versus-hose diseases (GVHD). Five with limited chronic GVHD had an indolent clinical course with involvement of only the skin and liver. Forty-seven with extensive chronic GVHD had an unfavorable multiorgan disorder that resembled several autoimmune diseases. Thirteen patients with extensive disease (group I) were not treated and only 2 survive with Karnofsky scores >- 70%. Mortality resulted from infections and morbidity from sica syndrome, pulmonary and hepatic insufficiency, scleroderma-like skin disease, and contractures. Another 13 (group II) received a median of 8 mo prednisone and/or a brief course of antithymocyte globulin, and 3 survive without disability. The other 21 (group III) were treated with a combination of prednisone (1.0 mg/kg/q.o.d.) and either cyclophosphamide, procarbazine, or azathioprine (all 1.5 mg/kg/day) for a median of 13 mo. Combination therapy was well tolerated with only modest myelotoxicity. Fifteen in group III had a good and 4 a fair response to treatment while 2 with no response died. Azathioprine and prednisone was the most effective regimen. All therapy has been discontinued in 12 group III patients: GVHD returned in 5 (including 2 who died in spite of retreatment) while 7 remain free of GVHD for a median of 11 (range 6-30) mo observation. Only I group III survivor is disabled and 16 of the original 21 are alive 2-4 yr after transplant with Karnofsky scores of 70%-100%. Thus, combination immmunosuppression appears to favorably affect and, in some cases, premanently arrest the adverse natural course of extensive chronic GVHD. 相似文献
102.
Continuous administration of synthetic ovine corticotropin-releasing factor in man. Physiological and pathophysiological implications. 下载免费PDF全文
H M Schulte G P Chrousos P W Gold J D Booth E H Oldfield G B Cutler Jr D L Loriaux 《The Journal of clinical investigation》1985,75(6):1781-1785
The continuous 24-h infusion of a maximally stimulating dose (1 micrograms/kg per h) of ovine corticotropin-releasing factor (CRF) in man caused a modest elevation of plasma cortisol (17.2 +/- 1.4 micrograms/dl) and urinary-free cortisol (173 +/- 43 micrograms/24 h) concentrations, which was far less than that seen with a maximally stimulating dose of ACTH (50.4 +/- 2.2 micrograms/dl and 1,200 +/- 94 micrograms/24 h, respectively). The circadian rhythms of plasma ACTH and cortisol were preserved during CRF administration. An intravenous bolus injection of 1 microgram/kg of ovine CRF given to normal volunteers under basal conditions resulted in elevated plasma ACTH and cortisol peak levels (28 +/- 6 pg/ml and 15.0 +/- 1.0 micrograms/dl, respectively). However, no plasma ACTH and cortisol responses were observed when an identical CRF stimulation test was given at the end of the continuous infusion. These findings suggest that the stimulatory activity of exogenous CRF on the ACTH-secreting cells of the pituitary gland is restrained by the negative feedback of cortisol. The persistent circadian rhythm of ACTH, despite a constant level of plasma CRF during the infusion, suggests that the circadian variation in the activity of the hypothalamic-pituitary-adrenal axis cannot be explained solely by circadian periodicity of the endogenous CRF stimulus. 相似文献
103.
104.
Briese J Schulte HM Sajin M Bamberger C Redlin K Milde-Langosch K Löning T Bamberger AM 《Virchows Archiv : an international journal of pathology》2008,453(1):121-96
Kangai (KAI)-1 (CD82) is a metastasis suppressor gene, which belongs to the family of tetraspanin proteins. A loss of KAI-1 expression is associated with the advanced stages of many human malignancies. The present study was designed to investigate the expression pattern of KAI-1 in the normal endometrium and uterine tumors and to correlate it with the expression of tumor suppressor protein p53. KAI-1 could be found in the normal endometrium throughout the menstrual cycle. Thirteen of 42 endometrial carcinomas demonstrated moderate KAI-1 expression, but low expression of p53. Twenty-nine of 42 endometrial carcinomas showed reduced or absent KAI-1 expression, which correlated with strong expression of p53 (p < 0.001). There were significant correlations between KAI-1 expression and histological type, e.g., 93% of endometrioid carcinomas displayed a low or moderate immunostaining for KAI-1, whereas nearly all of the serous/clear cell carcinomas were KAI-1 negative (p < 0.001); tumor grading, e.g., 73% of high grade tumors showed no KAI-1 expression (p < 0.001). Most of the investigated uterine sarcomas were negative for KAI-1, whereas they displayed a strong immunostaining for p53. In conclusion, KAI-1 and p53 show inverse expression. The reduced KAI-1 expression may be the result of dysregulated p53 function and could be an important step in the endometrial carcinogenesis. 相似文献
105.
Not only does breast milk provides an ideal nutrient composition for the newborn, but it also contains a variety of substances that may actively influence growth and development of the infant and stimulate neonatal protection against gastrointestinal diseases. Hormones, growth factors, cytokines and even whole cells are present in breast milk and act to establish biochemical and immunological communication between mother and child. In addition, milk nutrients such as nucleotides, glutamine and lactoferrin have been shown to influence gastrointestinal development and host defense. The unique properties of milk as a mediator of biochemical messages will be presented and the clinical significance of breastfeeding in the prevention of neonatal gastrointestinal diseases will be discussed. 相似文献
106.
107.
Strongly reduced expression of the cell cycle inhibitor p27 in endometrial neoplasia 总被引:18,自引:0,他引:18
A.-M. Bamberger Lutz Riethdorf Karin Milde-Langosch Christoph M. Bamberger Imke Thuneke Insa Erdmann Heinrich M. Schulte T. Löning 《Virchows Archiv : an international journal of pathology》1999,434(5):423-428
In the present study we investigated the expression of the cell cycle inhibitor p27 in endometrial neoplasia using immunohistochemistry
with a p27-specific antibody. Expression of p27 in endometrial carcinomas was compared with expression in the normal endometrium
throughout the cycle. Normal endometrial cells showed strong nuclear expression of p27. Expression was present throughout
the cycle and was stronger during the secretory phase. We found strongly reduced or abolished expression of p27 in endometrial
carcinoma (85.3% of cases). The 41 tumours analysed were classified according to p27 staining intensity and percentage of
positive cells into the following categories of p27 expression: negative/very low (56.0%); low (29.3%); moderate (14.7%) and
high (0.0%). All the p27-positive tumours were well-differentiated endometrioid carcinomas of malignancy grade G1. Comparison
with the p53 status showed that all tumours with strong p53 expression had low/negative p27 staining, while those that were
positive for p27 had negative/low p53 staining. Reduced or absent p27 levels were also observed by Western blot analysis both
in tumour samples and in HEC-1B endometrial adenocarcinoma cells. It thus seems that p27 expression is essential for the control
of normal endometrial proliferation, and reduced or absent p27 expression may be an important step in endometrial carcinogenesis.
Received: 23 September 1998 / Accepted: 7 January 1999 相似文献
108.
Human breast lesions: characterization with proton MR spectroscopy 总被引:31,自引:0,他引:31
109.
Allelic losses on chromosome arm 10q and mutation of the PTEN (MMAC1) tumour suppressor gene in primary and metastatic malignant melanomas 总被引:7,自引:0,他引:7
Reifenberger J Wolter M Boström J Büschges R Schulte KW Megahed M Ruzicka T Reifenberger G 《Virchows Archiv : an international journal of pathology》2000,436(5):487-493
Malignant melanomas frequently show loss of alleles on the long arm of chromosome 10. The PTEN (MMAC1) gene has been identified as a tumour suppressor gene at 10q23.3 that is mutated in various types of advanced human cancers.
We have investigated a series of 40 sporadic melanomas from 37 patients (15 primary cutaneous melanomas and 25 melanoma metastases)
for allelic losses on chromosome 10, as well as for deletion and mutation of the PTEN gene. Microsatellite analysis revealed loss of heterozygosity at loci located on 10q in tumours from 15 of 34 patients investigated
(44%). Somatic PTEN mutations were identified in melanomas from 4 of 37 patients (11%), all of whom had metastatic disease. In two of these patients,
the tumours had additionally lost one PTEN allele, indicating complete loss of wild-type PTEN in the tumour cells. Our findings corroborate that loss of heterozygosity on chromosome 10 is a frequent aberration in malignant
melanomas and implicate PTEN as a tumour suppressor gene inactivated by somatic mutation in a fraction of these tumours.
Received: 1 September 1999 / Accepted: 22 December 1999 相似文献
110.
Abdullah Mahmood Ali Michelle Kirby Michael Jansen Francis P. Lach Jennifer Schulte Thiyam Ramsing Singh Sat D. Batish Arleen D. Auerbach David A. Williams Amom Ruhikanta Meetei 《Human mutation》2009,30(7):E761-E770
Fanconi anemia (FA) is a rare autosomal recessive or X‐linked disorder characterized by aplastic anemia, cancer susceptibility and cellular sensitivity to DNA crosslinking agents. Eight FA proteins (FANCA, FANCB, FANCC, FANCE, FANCF, FANCG, FANCL and FANCM) and three non‐FA proteins (FAAP100, FAAP24 and HES1) form an FA nuclear core complex, which is required for monoubiquitination of the FANCD2‐FANCI dimer upon DNA damage. FANCL possesses a PHD/RING‐finger domain and is a putative E3 ubiquitin ligase subunit of the core complex. In this study, we report an FA patient with an unusual presentation belonging to the FA‐L complementation group. The patient lacks an obvious FA phenotype except for the presence of a café‐au‐lait spot, mild hypocellularity and a family history of leukemia. The molecular diagnosis and identification of the FA subgroup was achieved by FA complementation assay. We identified bi‐allelic novel mutations in the FANCL gene and functionally characterized them. To the best of our knowledge, this is the second reported case belonging to the FA‐L complementation group. © 2009 Wiley‐Liss, Inc. 相似文献